Royalty Pharma plcRPRXNASDAQ
LOADING
|||
Operating Income Contraction
Trending lower, modest growth trend.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$1.29B
Near historical average
Average (9y)
$1.26B
Historical baseline
Range
High:$2.62B
Low:$307.06M
CAGR
+5.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $1.29B | -13.4% |
| 2023 | $1.49B | +385.9% |
| 2022 | $307.06M | -78.5% |
| 2021 | $1.43B | -10.3% |
| 2020 | $1.60B | -39.2% |
| 2019 | $2.62B | +92.3% |
| 2018 | $1.36B | +45.2% |
| 2017 | $939.69M | +30.0% |
| 2016 | $722.87M | -9.0% |
| 2015 | $794.28M | - |